加州资源(CRC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CRC 加州资源

休市中 07-02 16:00:00 EDT

51.26

-0.49

-0.95%

盘后51.26

+0.000.00%

16:38 EDT

最高52.67	最低50.78	成交量68.80万
今开52.06	昨收51.75	日振幅3.66%
总市值45.42亿	流通市值45.36亿	总股本8,860万
成交额3,534万	换手率0.78%	流通股本8,850万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CRC","market":"US","secType":"STK","nameCN":"加州资源","latestPrice":51.26,"timestamp":1783022400000,"preClose":51.75,"halted":0,"volume":688045,"hourTrading":{"tag":"盘后","latestPrice":51.26,"preClose":51.26,"latestTime":"16:38 EDT","volume":15975,"amount":818878.58,"timestamp":1783024692972,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.009468599033816463,"floatShares":88496299,"shares":88597474,"eps":-5.357711,"marketStatus":"休市中","change":-0.49,"latestTime":"07-02 16:00:00 EDT","open":52.06,"high":52.67,"low":50.775,"amount":35336981.14994,"amplitude":0.036618,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.357711,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1783324800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1415854800000,"exchange":"NYSE","adjPreClose":51.75,"dividendRate":0.030921,"preHourTrading":{"tag":"盘前","latestPrice":51.9,"preClose":51.81,"latestTime":"08:14 EDT","volume":5,"amount":259.5,"timestamp":1782994440444,"change":0.09,"changeRate":0.001737,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":51.26,"preClose":51.26,"latestTime":"16:38 EDT","volume":15975,"amount":818878.58,"timestamp":1783024692972,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.639611565592284,"impliedVol":0.4651,"impliedVolPercentile":0.6335},"requestUrl":"/m/hq/s/CRC","defaultTab":"news","newsList":[{"id":"1143656174","title":"Gerdes能源研究上调加州资源评级至买入，目标价提升1美元至67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1143656174","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143656174?lang=zh_cn&edition=full","pubTime":"2026-06-24 13:53","pubTimestamp":1782280395,"startTime":"0","endTime":"0","summary":"Gerdes能源研究机构将加州资源的投资评级从中性上调至买入，同时将其目标股价提高了1美元，至每股67美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0266512127.USD","LU0456854461.SGD","CRC","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640921641","title":"核心管线数据利空 基石药业股价大跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2640921641","media":"21世纪经济报道","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640921641?lang=zh_cn&edition=full","pubTime":"2026-06-03 07:00","pubTimestamp":1780441200,"startTime":"0","endTime":"0","summary":"6月1日盘前，基石药业（2616.HK）宣布核心资产CS2009（PD-1/VEGF/CTLA-4三特异性抗体）的多项关键临床进展，于美国临床肿瘤学会（ASCO）年会上通过两份壁报正式发布，涵盖一线及后线非小细胞肺癌（NSCLC）及结直肠癌（CRC）患者I/II期临床试验数据，以及晚期实体瘤患者更长随访后的成熟I期临床数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606033757998235.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606033757998235.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0456854461.SGD","CRC","LU0266512127.USD","ORR","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640438958","title":"核心管线数据利空，基石药业股价大跌超32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640438958","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640438958?lang=zh_cn&edition=full","pubTime":"2026-06-01 18:05","pubTimestamp":1780308300,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者韩利明6月1日盘前，基石药业（2616.HK）宣布核心资产CS2009（PD-1/VEGF/CTLA-4三特异性抗体）的多项关键临床进展，于美国临床肿瘤学会（ASCO）年会上通过两份壁报正式发布，涵盖一线及后线非小细胞肺癌（NSCLC）及结直肠癌（CRC）患者I/II期临床试验数据，以及晚期实体瘤患者更长随访后的成熟I期临床数据。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606013756146980.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606013756146980.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ORR","BK4213","CRC","LU0456854461.SGD","LU0266512127.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640981923","title":"ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640981923","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640981923?lang=zh_cn&edition=full","pubTime":"2026-06-01 08:27","pubTimestamp":1780273622,"startTime":"0","endTime":"0","summary":"格隆汇6月1日丨基石药业-B宣布，公司核心资产CS2009的多项临床关键进展，于美国临床肿瘤学会年会上通过两份壁报正式发布，涵盖CS2009在一线及后线非小细胞肺癌和结直肠癌患者中的I/II期临床试验数据，以及晚期实体瘤患者更长随访后的成熟I期临床数据。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260601/32265512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK4213","LU0266512127.USD","BK1161","BK1574","LU0456854461.SGD","02616","CRC"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2637879691","title":"创胜集团医药-B(06628)合作伙伴INHIBRX报告OZEKIBART的CRC最新积极数据并宣布就治疗软骨肉瘤提交美国BLA申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2637879691","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637879691?lang=zh_cn&edition=full","pubTime":"2026-05-21 06:25","pubTimestamp":1779315934,"startTime":"0","endTime":"0","summary":"智通财经APP讯，创胜集团医药-B 发布公告，其合作伙伴Inhibrx Biosciences, Inc. 近期报告了其评估ozekibart 联合FOLFIRI用于局部晚期或转移性、不可切除结直肠癌患者的1/2期研究的积极更新中期数据。除CRC适应症外，Inhibrx宣布ozekibart于软骨肉瘤方面取得一项重要监管里程碑。于2026年4月，Inhibrx已向FDA提交ozekibart用于常规软骨肉瘤的BLA，而该疾病目前尚无获批准的系统性治疗选项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444232.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0456854461.SGD","159938","BK1515","09939","BK1161","LU0266512127.USD","06628","BK1574","CRC","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180996061","title":"加州资源公司上调2026年Berry并购年度协同效应目标中值12%至9-10亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1180996061","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180996061?lang=zh_cn&edition=full","pubTime":"2026-05-06 05:21","pubTimestamp":1778016090,"startTime":"0","endTime":"0","summary":"加州资源公司宣布将其2026年Berry并购交易产生的年度协同效应目标区间中值上调12%，新目标设定为9亿至10亿美元。此次调整反映出公司对合并后运营效率提升和成本节约潜力的更乐观评估。\n该能源企业通过优化资产整合与业务流程重组，预计将实现显著的经济效益。修订后的协同目标彰显了管理层对达成战略并购价值的坚定信心，也为投资者提供了更明确的财务指引。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRC","LU0266512127.USD","BK4213","LU0456854461.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161491384","title":"财报前瞻｜加州资源本季度营收预计增8.71%，机构观点偏向看多","url":"https://stock-news.laohu8.com/highlight/detail?id=1161491384","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161491384?lang=zh_cn&edition=full","pubTime":"2026-04-28 12:08","pubTimestamp":1777349302,"startTime":"0","endTime":"0","summary":"加州资源将于2026年05月05日盘后发布新财季业绩，市场关注产量目标推进、并购协同落地与利润率修复节奏。市场一致预期本季度加州资源营收为9.37亿美元，同比增加8.71%；调整后每股收益为0.85美元，同比增加8.68%，息税前利润预计为1.30亿美元，同比小幅增长0.26%。目前一致预期尚未给出本季度毛利率、净利率或净利润的明确指引，需待公司披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜加州资源本季度营收预计增8.71%，机构观点偏向看多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618909523","title":"Nextcure, Inc.盘中异动 临近收盘急速拉升6.06%报13.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618909523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618909523?lang=zh_cn&edition=full","pubTime":"2026-03-12 03:58","pubTimestamp":1773259100,"startTime":"0","endTime":"0","summary":"北京时间2026年03月12日03时58分，Nextcure, Inc.股票出现异动，股价大幅上涨6.06%。截至发稿，该股报13.48美元/股，成交量4.3323万股，换手率1.24%，振幅7.08%。Nextcure, Inc.股票所在的生物技术行业中，整体跌幅为1.01%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段的生物制药公司，致力于发现和开发新型、一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312035820a461f3bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312035820a461f3bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","CRC","LU0456854461.SGD","BK4139","NXTC","LU0266512127.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105766269","title":"加州资源公司增发2025年10月8日发行的4亿美元7.000%优先票据","url":"https://stock-news.laohu8.com/highlight/detail?id=1105766269","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105766269?lang=zh_cn&edition=full","pubTime":"2026-03-11 21:40","pubTimestamp":1773236420,"startTime":"0","endTime":"0","summary":"加州资源公司宣布，将对其于2025年10月8日发行的总额4亿美元、票面利率7.000%的优先票据进行增发。此次新发行的票据将与原有票据合并构成单一系列，具有同等优先级和条款。增发旨在进一步优化公司资本结构，为业务拓展提供灵活资金支持。该票据预计将延续相同到期日和利息支付安排，强化公司在能源市场的财务韧性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","LU0456854461.SGD","LU0266512127.USD","CRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616350999","title":"Nextcure, Inc.股价重挫16.82% 市值跌41.52万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616350999","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616350999?lang=zh_cn&edition=full","pubTime":"2026-03-02 22:38","pubTimestamp":1772462339,"startTime":"0","endTime":"0","summary":"北京时间2026年03月02日22时38分，Nextcure, Inc.股票出现异动，股价大幅下跌16.82%。截至发稿，该股报10.58美元/股，成交量1234股，换手率0.04%，振幅0.00%。Nextcure, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段的生物制药公司，致力于发现和开发新型、一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030222390097a7af0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030222390097a7af0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4213","NXTC","CRC","LU0456854461.SGD","LU0266512127.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110091409","title":"异动解读 | 加州资源盘前大涨5.37%，多重利好叠加提振市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1110091409","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110091409?lang=zh_cn&edition=full","pubTime":"2026-03-02 21:59","pubTimestamp":1772459967,"startTime":"0","endTime":"0","summary":"加州资源（CRC）今日盘前股价大幅上涨5.37%，引起了市场的广泛关注。消息面上，公司近期公布了积极的2026年生产目标，计划实现约12%的年度产量增长，预计日均产量将维持在152至157千桶油当量区间，增长目标由四台自主运营的钻井平台支撑。此外，公司已成功获得多项新钻探许可，掌握了推进其2026年资本计划所需的大部分关键牌照，为油气田开发项目的推进和未来产能扩张奠定了监管基础。同时，公司预计在完成与Berry公司的合并交易后12个月内，可实现高达8000万至9000万美元的协同效益，这将显著提升其运营效率与盈利能力。这些积极的业务进展共同提振了投资者对公司的未来前景的信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155217376","title":"加州资源：预计并购完成后12个月内实现8000万至9000万美元的Berry协同效应","url":"https://stock-news.laohu8.com/highlight/detail?id=1155217376","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155217376?lang=zh_cn&edition=full","pubTime":"2026-03-02 21:10","pubTimestamp":1772457016,"startTime":"0","endTime":"0","summary":"加州资源公司近日披露，预计在完成与Berry公司的合并交易后12个月内，可实现高达8000万至9000万美元的协同效益。这一财务目标凸显了并购案背后蕴藏的巨大价值创造潜力。\n通过业务整合与资源优化，两家企业将充分发挥互补优势，共同开拓更广阔的市场空间。此次协同效应的实现，将进一步提升公司的运营效率与盈利能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0266512127.USD","BK4213","LU0456854461.SGD","CRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139668251","title":"加州资源公司：斩获新钻探许可，已掌握2026年资本计划所需多数牌照","url":"https://stock-news.laohu8.com/highlight/detail?id=1139668251","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139668251?lang=zh_cn&edition=full","pubTime":"2026-03-02 21:09","pubTimestamp":1772456995,"startTime":"0","endTime":"0","summary":"加州资源公司（California Resources Corp）近期成功获得多项新钻探许可。目前，该公司已持有推进其2026年资本计划所需的大部分关键许可证。\n这一进展标志着加州资源在实施长期战略方面取得重要突破。新许可的落地将直接支持其油气田开发项目的推进，为未来产能扩张奠定监管基础。\n随着2026年资本计划所需牌照陆续到位，公司有望按计划启动新一轮钻井作业。此举不仅将强化其在加州油气市场的地位，也为后续资本投入提供了明确的时间表。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456854461.SGD","LU0266512127.USD","BK4213","CRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196098052","title":"加州资源：2026年产量展望目标约12%同比增长，四台运营钻机支撑日均152-157千桶油当量","url":"https://stock-news.laohu8.com/highlight/detail?id=1196098052","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196098052?lang=zh_cn&edition=full","pubTime":"2026-03-02 21:09","pubTimestamp":1772456956,"startTime":"0","endTime":"0","summary":"加州资源公司近期公布2026年生产目标，计划实现约12%的年度产量增长。该公司预计日均产量将维持在152至157千桶油当量区间，这一增长目标将依托四台自主运营的钻井平台提供支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0266512127.USD","BK4213","LU0456854461.SGD","CRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613200160","title":"MIRXES-B(02629)完成CADENCE CRC的入组程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2613200160","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613200160?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:37","pubTimestamp":1771835851,"startTime":"0","endTime":"0","summary":"智通财经APP讯，MIRXES-B 发布公告，本公司已完成CADENCE CRC的入组程序，CADENCE CRC是一项大型前瞻性临床研究，旨在验证其血液检测于平均风险及高风险成人群体中筛查结直肠癌的有效性。CADENCE CRC于东南亚招募逾6000名受试者，是该地区首项且规模最大用以评估基于血液检测结直肠癌筛查测试的注册性研究。CADENCE CRC设计为一项前瞻性验证研究，旨在支持本公司结直肠癌筛查血液检测获得监管批准及临床采用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406309.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02629","BK4213","CRC","LU0456854461.SGD","LU0266512127.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155394844","title":"财报前瞻｜加州资源本季度营收预计减14.00%，机构观点偏向看多","url":"https://stock-news.laohu8.com/highlight/detail?id=1155394844","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155394844?lang=zh_cn&edition=full","pubTime":"2026-02-23 10:24","pubTimestamp":1771813463,"startTime":"0","endTime":"0","summary":"加州资源将于2026年03月02日发布最新季度财报，市场关注营收与盈利的同比变化及分业务表现。市场一致预期本季度加州资源营收为7.72亿美元，同比下降14.00%；调整后每股收益为0.53美元，同比下降45.36%；息税前利润为8,024.94万USD，同比下降43.71%。当前共识未提供本季度毛利率或净利率的明确指引，预计披露时点后再行确认。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜加州资源本季度营收预计减14.00%，机构观点偏向看多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609587456","title":"加州资源盘中异动 早盘股价大跌5.03%报53.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609587456","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609587456?lang=zh_cn&edition=full","pubTime":"2026-02-06 00:05","pubTimestamp":1770307546,"startTime":"0","endTime":"0","summary":"北京时间2026年02月06日00时05分，加州资源股票出现异动，股价大幅下挫5.03%。截至发稿，该股报53.10美元/股，成交量18.8414万股，换手率0.21%，振幅4.41%。最近的财报数据显示，该股实现营业收入8.78亿美元，净利润64.00百万美元，每股收益0.76美元，毛利3.37亿美元，市盈率12.75倍。机构评级方面，在所有16家参与评级的机构中，81%的券商给予买入建议，19%的券商给予持有建议，无券商给予卖出建议。加州资源股票所在的油气勘探开发行业中，整体跌幅为2.48%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206000546954006d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206000546954006d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","LU0456854461.SGD","LU0266512127.USD","CRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608358502","title":"Nextcure, Inc.盘中异动 股价大涨8.33%报11.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608358502","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608358502?lang=zh_cn&edition=full","pubTime":"2026-02-04 01:04","pubTimestamp":1770138295,"startTime":"0","endTime":"0","summary":"北京时间2026年02月04日01时04分，Nextcure, Inc.股票出现异动，股价快速拉升8.33%。截至发稿，该股报11.84美元/股，成交量1.2307万股，换手率0.35%，振幅4.21%。Nextcure, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段的生物制药公司，致力于发现和开发新型、一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020401045597a4b6fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020401045597a4b6fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NXTC","LU0266512127.USD","BK4139","LU0456854461.SGD","BK4213","CRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606132477","title":"Nextcure, Inc.盘中异动 大幅下挫5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606132477","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606132477?lang=zh_cn&edition=full","pubTime":"2026-01-28 04:02","pubTimestamp":1769544127,"startTime":"0","endTime":"0","summary":"北京时间2026年01月28日04时02分，Nextcure, Inc.股票出现异动，股价急速下跌5.82%。Nextcure, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段的生物制药公司，致力于发现和开发新型、一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012804020897a3a6f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012804020897a3a6f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0456854461.SGD","NXTC","BK4213","CRC","LU0266512127.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603291565","title":"Nextcure, Inc.盘中异动 股价大涨5.46%报14.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603291565","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603291565?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:35","pubTimestamp":1768228518,"startTime":"0","endTime":"0","summary":"北京时间2026年01月12日22时35分，Nextcure, Inc.股票出现波动，股价大幅上涨5.46%。截至发稿，该股报14.10美元/股，成交量193股，换手率0.01%，振幅0.00%。Nextcure, Inc.股票所在的生物技术行业中，整体跌幅为1.19%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段的生物制药公司，致力于发现和开发新型、一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112223518a4bb11d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112223518a4bb11d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0456854461.SGD","BK4139","CRC","LU0266512127.USD","BK4213","NXTC"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.crc.com","stockEarnings":[{"period":"1week","weight":-0.0469},{"period":"1month","weight":-0.1693},{"period":"3month","weight":-0.2431},{"period":"6month","weight":0.105},{"period":"1year","weight":0.0953},{"period":"ytd","weight":0.1465}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":-0.0195},{"period":"3month","weight":0.1356},{"period":"6month","weight":0.0902},{"period":"1year","weight":0.2004},{"period":"ytd","weight":0.0922}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"California Resources Corporation于2014年4月23日在特拉华州注册成立。该公司从Occidental公司分离出来之后是一家独立的石油和天然气勘探和生产公司，专注于高增长，高回报在加利福尼亚州的常规和非常规资产。加利福尼亚州是世界上最丰富的石油和天然气生产地区之一，是全美国第三大石油生产州。该公司在加利福尼亚州的总经营的基础上是最大的生产商。","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.004081},{"month":2,"riseRate":0.5,"avgChangeRate":0.032338},{"month":3,"riseRate":0.5,"avgChangeRate":0.021791},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.055622},{"month":5,"riseRate":0.5,"avgChangeRate":0.046881},{"month":6,"riseRate":0.666667,"avgChangeRate":0.029443},{"month":7,"riseRate":0.5,"avgChangeRate":0.044478},{"month":8,"riseRate":1,"avgChangeRate":0.085846},{"month":9,"riseRate":0.6,"avgChangeRate":0.008098},{"month":10,"riseRate":0.4,"avgChangeRate":0.023069},{"month":11,"riseRate":0.666667,"avgChangeRate":0.101056},{"month":12,"riseRate":0.5,"avgChangeRate":0.002283}],"exchange":"NYSE","name":"加州资源","nameEN":"California Resources"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"加州资源(CRC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供加州资源(CRC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"加州资源,CRC,加州资源股票,加州资源股票老虎,加州资源股票老虎国际,加州资源行情,加州资源股票行情,加州资源股价,加州资源股市,加州资源股票价格,加州资源股票交易,加州资源股票购买,加州资源股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"加州资源(CRC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供加州资源(CRC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}